Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002520 · ClinicalTrials.gov registry record · NA
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
A NA study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 434
- Enrollment target
NCT00002520: Completed NA study, sponsored by Eastern Cooperative Oncology Group.
NCT00002520 is a NA study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 434 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002520, a NA study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 434 participants
- Enrollment target
Study Summary
RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for early-stage cancer.
Primary Outcome
Proportion of patients who have quit smoking 6 months after the intervention
Interventions
- BEHAVIORAL Usual Care
- DRUG nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 1990-12-07 |
| Phase | NA |
What the finished NCT00002520 record still lists
NCT00002520 is an interventional study that assigns participants to a tested intervention. The registered 434 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00002520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002520 about?
NCT00002520 is a clinical study titled "Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer". RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinical trial to compare the effectiveness of a physician-initiated stop-smoking program with the usual care for patients receiving treatment for...
What is the current status of trial NCT00002520?
This trial is currently completed. It is a NA study. The enrollment target is 434 participants. The study started on 1990-12-07.
What interventions are being tested in trial NCT00002520?
The interventions under investigation include: Usual Care (BEHAVIORAL), nicotine (DRUG).
Who is sponsoring clinical trial NCT00002520?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002520's enrollment target sits among peer trials
434 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI